Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating hormone concentration (HP:0003117)help
Parent Node:
expand
Abnormality of circulating glucocorticoid level (HP:0012111)help
..Starting node
..expand
Abnormality of circulating cortisol level (HP:0011731)help
Term ID: 11731
Name: Abnormality of circulating cortisol level
Synonym:
Definition: An abnormality of the concentration of cortisol in the blood.
Comments:
Reference: HP:0011731
Genes and Diseases:
 
       Child Nodes:
........expandIncreased circulating cortisol level (HP:0003118) help
................... HP:0001579 Primary hypercorticolism
................... HP:0011744 Secondary hypercorticolism
................... HP:0025436 Elevated serum 11-deoxycortisol
........expandParadoxical increased cortisol secretion on dexamethasone suppression test (HP:0003466) help
........expandDecreased circulating cortisol level (HP:0008163) help

 Sister Nodes: 
..expandAbnormal circulating corticosterone level (HP:0012112) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011731HP:0011731Abnormality of circulating cortisol level0AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome57
HP:0011731HP:0011731Abnormality of circulating cortisol level0ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophy135
HP:0011731HP:0011731Abnormality of circulating cortisol level0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 192
HP:0011731HP:0011731Abnormality of circulating cortisol level0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0011731HP:0011731Abnormality of circulating cortisol level0ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0011731HP:0011731Abnormality of circulating cortisol level0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011731HP:0011731Abnormality of circulating cortisol level0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011731HP:0011731Abnormality of circulating cortisol level0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0011731HP:0011731Abnormality of circulating cortisol level0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinoma289
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0011731HP:0011731Abnormality of circulating cortisol level0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0011731HP:0011731Abnormality of circulating cortisol level0CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinoma88
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency112
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronism73
HP:0011731HP:0011731Abnormality of circulating cortisol level0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0011731HP:0011731Abnormality of circulating cortisol level0GATB CL E G H51888849OMIM:618838COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41
HP:0011731HP:0011731Abnormality of circulating cortisol level0GATC CL E G H28345925068OMIM:618839COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD421
HP:0011731HP:0011731Abnormality of circulating cortisol level0GLI3 CL E G H27374319OMIM:146510Pallister-Hall syndrome270
HP:0011731HP:0011731Abnormality of circulating cortisol level0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia101
HP:0011731HP:0011731Abnormality of circulating cortisol level0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011731HP:0011731Abnormality of circulating cortisol level0GNAS CL E G H27784392ORPHA:562McCune-Albright syndrome101
HP:0011731HP:0011731Abnormality of circulating cortisol level0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic101
HP:0011731HP:0011731Abnormality of circulating cortisol level0HSD11B2 CL E G H32915209ORPHA:320Apparent mineralocorticoid excessHP:0040282 - Frequent14
HP:0011731HP:0011731Abnormality of circulating cortisol level0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency34
HP:0011731HP:0011731Abnormality of circulating cortisol level0HTR1A CL E G H33505286OMIM:614674Periodic fever, menstrual cycle-dependent2
HP:0011731HP:0011731Abnormality of circulating cortisol level0KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0011731HP:0011731Abnormality of circulating cortisol level0MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiency94
HP:0011731HP:0011731Abnormality of circulating cortisol level0MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 194
HP:0011731HP:0011731Abnormality of circulating cortisol level0MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0011731HP:0011731Abnormality of circulating cortisol level0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0011731HP:0011731Abnormality of circulating cortisol level0MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiency26
HP:0011731HP:0011731Abnormality of circulating cortisol level0MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 226
HP:0011731HP:0011731Abnormality of circulating cortisol level0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0011731HP:0011731Abnormality of circulating cortisol level0NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndrome11
HP:0011731HP:0011731Abnormality of circulating cortisol level0NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiency13
HP:0011731HP:0011731Abnormality of circulating cortisol level0NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital48
HP:0011731HP:0011731Abnormality of circulating cortisol level0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011731HP:0011731Abnormality of circulating cortisol level0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndrome79
HP:0011731HP:0011731Abnormality of circulating cortisol level0PCSK1 CL E G H51228743OMIM:600955Proprotein convertase 1/3 deficiency65
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 213
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDE8B CL E G H86228794OMIM:614190Pigmented nodular adrenocortical disease, primary, 375
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011731HP:0011731Abnormality of circulating cortisol level0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0011731HP:0011731Abnormality of circulating cortisol level0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0011731HP:0011731Abnormality of circulating cortisol level0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 42
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinoma134
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0011731HP:0011731Abnormality of circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011731HP:0011731Abnormality of circulating cortisol level0QRSL1 CL E G H5527821020OMIM:618835COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40
HP:0011731HP:0011731Abnormality of circulating cortisol level0RET CL E G H59799967OMIM:171400Multiple endocrine neoplasia, type IIA572
HP:0011731HP:0011731Abnormality of circulating cortisol level0SERPINA6 CL E G H8661540OMIM:611489Corticosteroid-binding globulin deficiency4
HP:0011731HP:0011731Abnormality of circulating cortisol level0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0011731HP:0011731Abnormality of circulating cortisol level0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0011731HP:0011731Abnormality of circulating cortisol level0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0011731HP:0011731Abnormality of circulating cortisol level0STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiency45
HP:0011731HP:0011731Abnormality of circulating cortisol level0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0011731HP:0011731Abnormality of circulating cortisol level0TBX19 CL E G H909511596OMIM:201400Acth deficiency, isolated57
HP:0011731HP:0011731Abnormality of circulating cortisol level0TBX19 CL E G H909511596ORPHA:199296Congenital isolated ACTH deficiency57
HP:0011731HP:0011731Abnormality of circulating cortisol level0TERT CL E G H701511730ORPHA:1501Adrenocortical carcinoma238
HP:0011731HP:0011731Abnormality of circulating cortisol level0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0011731HP:0011731Abnormality of circulating cortisol level0TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinoma911
HP:0011731HP:0011731Abnormality of circulating cortisol level0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011731HP:0011731Abnormality of circulating cortisol level0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0011731HP:0011731Abnormality of circulating cortisol level0TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiency85
HP:0011731HP:0011731Abnormality of circulating cortisol level0TXNRD2 CL E G H1058718155OMIM:617825GLUCOCORTICOID DEFICIENCY 5; GCCD585
HP:0011731HP:0011731Abnormality of circulating cortisol level0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011731HP:0011731Abnormality of circulating cortisol level0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011731HP:0011731Abnormality of circulating cortisol level0ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinoma
HP:0011731HP:0008163Decreased circulating cortisol level1AAAS CL E G H808613666OMIM:231550Achalasia-Addisonianism-Alacrima syndrome.57
HP:0011731HP:0008163Decreased circulating cortisol level1ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040281 - Very frequent135
HP:0011731HP:0003118Increased circulating cortisol level1AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0011731HP:0008163Decreased circulating cortisol level1AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0011731HP:0003118Increased circulating cortisol level1ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0011731HP:0003118Increased circulating cortisol level1ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011731HP:0003118Increased circulating cortisol level1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011731HP:0008163Decreased circulating cortisol level1BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0011731HP:0003118Increased circulating cortisol level1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011731HP:0003118Increased circulating cortisol level1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011731HP:0003118Increased circulating cortisol level1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0011731HP:0003118Increased circulating cortisol level1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0011731HP:0003118Increased circulating cortisol level1CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040283 - Occasional102
HP:0011731HP:0003118Increased circulating cortisol level1CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0011731HP:0003118Increased circulating cortisol level1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0011731HP:0003118Increased circulating cortisol level1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0011731HP:0003118Increased circulating cortisol level1CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0011731HP:0008163Decreased circulating cortisol level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0011731HP:0008163Decreased circulating cortisol level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0011731HP:0003118Increased circulating cortisol level1CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0011731HP:0008163Decreased circulating cortisol level1CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040281 - Very frequent112
HP:0011731HP:0003118Increased circulating cortisol level1CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronism73
HP:0011731HP:0008163Decreased circulating cortisol level1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0011731HP:0008163Decreased circulating cortisol level1GATB CL E G H51888849OMIM:618838COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41
HP:0011731HP:0008163Decreased circulating cortisol level1GATC CL E G H28345925068OMIM:618839COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD421
HP:0011731HP:0008163Decreased circulating cortisol level1GLI3 CL E G H27374319OMIM:146510Pallister-Hall syndrome270
HP:0011731HP:0003118Increased circulating cortisol level1GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0011731HP:0003118Increased circulating cortisol level1GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011731HP:0003118Increased circulating cortisol level1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0011731HP:0003118Increased circulating cortisol level1GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0011731HP:0008163Decreased circulating cortisol level1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0011731HP:0003118Increased circulating cortisol level1HTR1A CL E G H33505286OMIM:614674Periodic fever, menstrual cycle-dependentHP:0040283 - Occasional2
HP:0011731HP:0003118Increased circulating cortisol level1KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0011731HP:0008163Decreased circulating cortisol level1MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate94
HP:0011731HP:0008163Decreased circulating cortisol level1MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 1.94
HP:0011731HP:0003118Increased circulating cortisol level1MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1.462
HP:0011731HP:0003118Increased circulating cortisol level1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0011731HP:0008163Decreased circulating cortisol level1MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate26
HP:0011731HP:0008163Decreased circulating cortisol level1MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 2.26
HP:0011731HP:0008163Decreased circulating cortisol level1NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0011731HP:0008163Decreased circulating cortisol level1NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndromeHP:0040281 - Very frequent11
HP:0011731HP:0008163Decreased circulating cortisol level1NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate13
HP:0011731HP:0008163Decreased circulating cortisol level1NR0B1 CL E G H1907960OMIM:300200Adrenal hypoplasia, congenital.48
HP:0011731HP:0003118Increased circulating cortisol level1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011731HP:0003118Increased circulating cortisol level1NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040281 - Very frequent79
HP:0011731HP:0008163Decreased circulating cortisol level1PCSK1 CL E G H51228743OMIM:600955Proprotein convertase 1/3 deficiency.65
HP:0011731HP:0003118Increased circulating cortisol level1PDE11A CL E G H509408773ORPHA:1359Carney complexHP:0040282 - Frequent13
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0011731HP:0003118Increased circulating cortisol level1PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011731HP:0003118Increased circulating cortisol level1PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011731HP:0003118Increased circulating cortisol level1PDE8B CL E G H86228794OMIM:614190Pigmented nodular adrenocortical disease, primary, 3.75
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011731HP:0003118Increased circulating cortisol level1PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011731HP:0008163Decreased circulating cortisol level1PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0011731HP:0008163Decreased circulating cortisol level1PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0011731HP:0008163Decreased circulating cortisol level1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040282 - Frequent76
HP:0011731HP:0003118Increased circulating cortisol level1PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011731HP:0003118Increased circulating cortisol level1PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011731HP:0003118Increased circulating cortisol level1PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0011731HP:0003118Increased circulating cortisol level1PRKAR1A CL E G H55739388ORPHA:1359Carney complexHP:0040282 - Frequent134
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0011731HP:0003118Increased circulating cortisol level1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0011731HP:0003118Increased circulating cortisol level1PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011731HP:0008163Decreased circulating cortisol level1QRSL1 CL E G H5527821020OMIM:618835COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40
HP:0011731HP:0003118Increased circulating cortisol level1RET CL E G H59799967OMIM:171400Multiple endocrine neoplasia, type IIA.572
HP:0011731HP:0008163Decreased circulating cortisol level1SERPINA6 CL E G H8661540OMIM:611489Corticosteroid-binding globulin deficiency4
HP:0011731HP:0008163Decreased circulating cortisol level1SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0011731HP:0008163Decreased circulating cortisol level1SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0011731HP:0008163Decreased circulating cortisol level1SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0011731HP:0008163Decreased circulating cortisol level1STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate45
HP:0011731HP:0008163Decreased circulating cortisol level1SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0011731HP:0008163Decreased circulating cortisol level1TBX19 CL E G H909511596OMIM:201400Acth deficiency, isolated.57
HP:0011731HP:0008163Decreased circulating cortisol level1TBX19 CL E G H909511596ORPHA:199296Congenital isolated ACTH deficiencyHP:0040280 - Obligate57
HP:0011731HP:0003118Increased circulating cortisol level1TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0011731HP:0008163Decreased circulating cortisol level1TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0011731HP:0003118Increased circulating cortisol level1TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011731HP:0003118Increased circulating cortisol level1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011731HP:0008163Decreased circulating cortisol level1TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0011731HP:0008163Decreased circulating cortisol level1TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiencyHP:0040280 - Obligate85
HP:0011731HP:0008163Decreased circulating cortisol level1TXNRD2 CL E G H1058718155OMIM:617825GLUCOCORTICOID DEFICIENCY 5; GCCD585
HP:0011731HP:0003118Increased circulating cortisol level1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011731HP:0003118Increased circulating cortisol level1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011731HP:0003118Increased circulating cortisol level1ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent
HP:0011731HP:0003466Paradoxical increased cortisol secretion on dexamethasone suppression test1ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent
HP:0011731HP:0011744Secondary hypercortisolism2 CL E G H
HP:0011731HP:0001579Primary hypercortisolism2CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0011731HP:0001579Primary hypercortisolism2CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0011731HP:0001579Primary hypercortisolism2CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0011731HP:0001579Primary hypercortisolism2CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronismHP:0040282 - Frequent73
HP:0011731HP:0001579Primary hypercortisolism2GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0011731HP:0001579Primary hypercortisolism2GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0011731HP:0001579Primary hypercortisolism2MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0011731HP:0001579Primary hypercortisolism2PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0011731HP:0001579Primary hypercortisolism2PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0011731HP:0001579Primary hypercortisolism2PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0011731HP:0025436Elevated serum 11-deoxycortisol2ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent


Genes (59) :AAAS ABCD1 AIRE AKT1 ARMC5 ATRX BAP1 BRAF CDH23 CDKN1A CDKN1B CDKN2A CDKN2B CDKN2C CTNNB1 CYP11A1 CYP11B1 CYP11B2 CYP17A1 GATB GATC GLI3 GNAS HSD11B2 HSD3B2 HTR1A KCNJ11 MC2R MEN1 MRAP NF2 NFKB2 NNT NR0B1 NR3C1 PCSK1 PDE11A PDE8B PDGFB PIK3CA POR PRKACA PRKAR1A QRSL1 RET SERPINA6 SMARCB1 SMARCE1 SMO STAR SUFU TBX19 TERT TP53 TRAF7 TXNRD2 USP48 USP8 ZNRF3

Diseases (47) :OMIM:231550 ORPHA:139396 ORPHA:3453 ORPHA:2495 OMIM:615954 ORPHA:189427 ORPHA:96253 ORPHA:652 ORPHA:276152 ORPHA:1501 ORPHA:168558 ORPHA:289548 OMIM:202010 ORPHA:90795 ORPHA:556030 ORPHA:90793 OMIM:618838 OMIM:618839 OMIM:146510 OMIM:219080 ORPHA:562 OMIM:174800 ORPHA:320 ORPHA:90791 OMIM:614674 ORPHA:79644 ORPHA:361 OMIM:202200 OMIM:131100 OMIM:607398 ORPHA:293978 OMIM:300200 ORPHA:786 OMIM:600955 ORPHA:1359 OMIM:610475 ORPHA:189439 OMIM:614190 ORPHA:95699 OMIM:615830 OMIM:610489 OMIM:618835 OMIM:171400 OMIM:611489 OMIM:201400 ORPHA:199296 OMIM:617825
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.